Use of melatonin for treating androgenetic and diffuse alopecia

Abstract

The invention relates to the use of melatonin and melatonin-containing preparations for the treatment of androgenetic and diffuse alopecia of the female type.

1 . The use of melatonin for producing a composition for the treatment of androgenetic and diffuse alopecia of the female type.  
     
     
         2 . The use as claimed in  claim 1 , wherein the composition can be applied topically.  
     
     
         3 . The use as claimed in  claim 1  or  2 , wherein the composition can be applied as a spray, solution, lotion, cream or ointment.  
     
     
         4 . The use as claimed in one of the preceding claims, wherein the melatonin preparation has an active compound concentration of 0.001 to 1% (wt/wt).  
     
     
         5 . The use as claimed in one of the preceding claims, wherein the amount of the composition applied daily contains an active compound dose of 0.01 to 10 mg per day.  
     
     
         6 . The use as claimed in one of the preceding claims, wherein a reduction in the telogenic rate is achieved.  
     
     
         7 . The use as claimed in one of the preceding claims, wherein an increase in the anagenic rate is achieved.  
     
     
         8 . The use as claimed in one of the preceding claims, wherein an enlargement of the hair diameter and/or an increase in the breaking force of the hair is achieved.  
     
     
         9 . The use of melatonin for producing a composition for enlarging the hair diameter and/or increasing the stretching ability in the case of diffuse alopecia.  
     
     
         10 . The use as claimed in  claim 9 . in the case of occipital hair.  
     
     
         11 . The use as claimed in  claim 9  or  10  in female patients.